| |
 Yantai Zhichu Pharmaceutical Co., Ltd. was entered into partnership and built by Zhichu Group and China Medicine Industrial Company in 1988. It has already formed six main workshops now and the fixed assets are 1. 400 million yuan. It can produce five kinds of dosage-forms, 68 products of different specifications and varieties. It is a comprehensives big (2) type enterprise with self-operation export and import right of foreign trade and becomes the largest antibiotic production base of eastern Shandong area. The production scale of gentamicin sulphate acid has already occupied the first place in the world. It is It is one of the leading enterprises and one of the main enterprises earning foreign exchange.
Yantai Zhichu Pharmaceutical Co., Ltd. covers an area of 100,000 square meters, of which the construction area is 45,000 square meters. There are 805 workers now. The production scale is 145000 1 billion of raw material medicine, 1 billion tablets, 50 million capsules, 1 million boxes of medicinal granules, 1 billion pieces of water thimble. The production factories are designed and constructed according to the quality of medicine production. There are advanced craft with intelligent heat-source determinators, intelligent stripping –degree determinators, automatic determinators, high performance liquid chromatograph these advanced quality detection means. At the same time the company adopts the advanced production technology in order to make several production targets such as production level; cost and so on to occupy the domestic advanced ranks .It ha been regarded as the new high-tech enterprise by the provincial scientific and technological commission in 1996.
The leading product gentamicin sulphate gains 40% export share and 1/4 domestic market with its have high-new technological level, the national lowest cost expenses and good product quality. In 2000, it has invested over 30 million again to build high-standard GMP formulation workshop and has already put them into use. The company regards technological progress as the guide; regards transformation of enterprise's system as the opportunity .The company has developed rapidly and moved to maturity progressively. The company has major related research room of formation, traditional Chinese medicine, formulation, biology, physics and chemistry and a pilot scale research base. The new medicine develop varieties include many varieties and many dosages such as Western medicine, traditional Chinese medicine, biological products etc. The development in the national-level new medicine, especially the research of the chemosynthesis medicine has quite strong strength. At present, the company has already set up the environmental protective measures in conformity with scale of the enterprise. The company has invested over 10 million to introduce American advanced sewage disposal equipment and has already built up industrial sewage center disposal station. Now it has dealt with waste water amount 185 million tons which reaches the national discharge standard to discharge
|
|
